This article provides an overview of the QuitNic pilot trial, which explores the feasibility of using nicotine vaping products as an alternative to traditional nicotine replacement therapies for individuals recovering from substance use disorders.
The study aims to inform future strategies for supporting smokers in maintaining abstinence after detoxification, with potential implications for public health policies.